Top Abstract Purchase Related
Home
>
Node
>
Subnode

Behavior of heparinocytes and fibrinolytic degradation products under sulfobromophthalein or indocyanine green in patients with liver diseases or persons with healthy liver

Frick, G.; Frick, U.; Brügmann, E.

Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 31(15): 579-583

1976

ISSN/ISBN: 0044-2542
PMID: 997652
Document Number: 106855
Due to a slight haemooysis after the application of bromsulphalein an intravasal coagulation with reduction of the number of heparinocytes and an increase of fibrinolytic split products develops. These changes are to be observed in the vast majority of tests, also in such cases where no clinical signs of an incompatibility appear. Indocyanine-green does not cause these severe disturbances of coagulation. Slight changes are traced back to the examination technique. Patients with chronic liver disease already show increased values of fibrinolytic split products. In increased initial values of fibrinolytic split products bromsulphalein does not cause a further increase.

Document emailed within 1 workday
Secure & encrypted payments

Kratz, F. 1978: Microsomal oxidative foreign-substance degradation by the human liver. Oxidative foreign-substance degradation by microsomal fractions of the liver withdrawn by needle biopsy, illustrated on the example of coumarin-7-hydroxylase and 7-ethoxycoumarin hydroxylase in persons with healthy livers and various liver diseases Fortschritte der Medizin 96(8): 393-397
Bolognesi, M.; Merkel, C.; Angeli, P.; Caregaro, L.; Gatta, A. 1988: Liver metabolism of indocyanine green and aminopyrine in liver cirrhosis: relations with functioning liver cell mass Minerva Medica 79(12): 1035-1041
Pirwitz, B.; Milewski, B. 1976: Comparative evaluation of dye clearance tests with the use of bromsulphalein, indocyanine green, radioactive rose bengal in the diagnosis of chronic liver diseases Polski Tygodnik Lekarski 31(1): 19-21
Frick, G.; Göretzlehner, G.; Frick, U. 1976: Action of prostaglandin F2 alpha on heparinocytes and fibrinolytic split products Acta Biologica et Medica Germanica 35(8-9): 1255-1256
Nakamuta, M.; Katsuda, Y.; Sakamoto, S.; Nawata, H. 1992: A case of constitutional indocyanine green excretory defect with abnormal retention of sulfobromophthalein: a new functional disorder? American Journal of Gastroenterology 87(7): 930-931
Mikulecký, M. 1977: Concerning the standardization of the liver function test by indocyanine green Bratislavske Lekarske Listy 67(5): 503-511
Skorka, G.; Bien, E. 1980: Bromosulfan and indocyanine green test in liver-damaged rats Acta Biologica et Medica Germanica 39(2-3): 271-276
Janecki, J.; Milewski, B. 1970: Diagnosis of compensated liver cirrhosis with indocyanine green (ujoviridih) test Zeitschrift für die Gesamte Innere Medizin und Ihre Grenzgebiete 25(11): 505-508
Müller, P.H.; Egberts, E.H.; Held, W.; Junger, K.; Schmülling, R.; Prestele, H.; Horbach, L.; Malchow, H. 1981: Carbohydrate infusion in internal diseases. a comparative study of metabolically healthy persons and liver disease and diabetic patients. III. Glucose infusion over a 48-hour period Infusionstherapie und Klinische Ernahrung 8(6): 266-269
Luft, D. 1981: Carbohydrate infusion in internal diseases. a comparative study in metabolically healthy patients, patients with liver diseases and diabetic patients. I. Physiopathologic aspects in the parenteral administration of monosaccharides Infusionstherapie und Klinische Ernahrung 8(4): 163-171
Lazúrová, I.; Lichardus, B.; Luczy, J.; Rosochová, I.; Trejbal, D.; Machánová, Y.; Hildebrand, T.; Fedorová, E.; Murár, J. 1994: The effect of water immersion on humoral and urinary parameters in healthy persons and in patients with liver cirrhosis Bratislavske Lekarske Listy 95(1): 29-33
Tashev, T.; Goranov, I.; Brailski, K.; Kolarski, V.; Nenov, P. 1973: Evaluation of indocyanine clearance in the diagnosis of parenchymal liver diseases Vutreshni Bolesti 12(6): 42-51
Pstruzinová, H.; Rovenská, A.; Goderová, Z.; Kristan, M. 1980: Examination of fibrin degradation products in cirrhosis of liver Casopis Lekaru Ceskych 119(1): 7-11
Wolff, H. 1970: The behavior of liver cholinesterase in liver, gallbladder and stomach diseases Zentralblatt für Chirurgie 95(19): 589-591
Bahre, G.; Kley, R.; Holzhüter, H. 1975: Comparative studies on the effect of ethanol on various laboratory chemical parameters in healthy persons and in patients with histologically verified lesions of the liver parenchyma Münchener Medizinische Wochenschrift 117(20): 841
De Matteis, F.; Gibbs, A.H.; Unseld, A.P. 1981: Conversion of liver haem into N-substituted porphyrins or green pigments. Evidence for two distinct classes of products Advances in Experimental Medicine and Biology 136 Pt B: 1319-1334
De Franchis, R.; Tornaghi, G.; Bellobuono, A.; Bitto, T.; Mirabile, E.; Del Ninno, E.; Ideo, G. 1972: Behavior of some mitochondrial enzymes in the blood of patients with various liver diseases Quaderni Sclavo di Diagnostica Clinica E di Laboratorio 8(1): 262-270
Frick, U.; Friemel, H. 1974: Quantitative determination of fibrinolytic degradation products by means of electroimmunodiffusion Folia Haematologica 101(5): 826-832
Frick, V.U. 1976: Determination and importance of fibrinolytic degradation products in surgical operations Zentralblatt für Chirurgie 101(5): 294-297
Okerengwo, A.A.; Atoba, M.A. 1992: Immune complex levels and HBs-antigenaemia in healthy Nigerians and patients with liver diseases African Journal of Medicine and Medical Sciences 21(2): 35-38